Loading…
Doximity, Inc. is projected to rise to $27.05 by 2027, a +24% move from its current price of $21.77. DOCS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $21.23 | $21.77 | $22.33 | +0.01% |
| Jul 14 | $21.02 | $21.78 | $22.56 | +0.03% |
| Jul 15 | $20.85 | $21.78 | $22.75 | +0.04% |
| Jul 16 | $20.72 | $21.78 | $22.90 | +0.05% |
| Jul 17 | $20.60 | $21.78 | $23.04 | +0.06% |
| Jul 18 | $20.49 | $21.79 | $23.17 | +0.08% |
| Jul 19 | $20.39 | $21.79 | $23.28 | +0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $20.39 | $21.79 | $23.28 | +0.09% |
| Week 2 | $19.85 | $21.81 | $23.96 | +0.18% |
| Week 3 | $19.46 | $21.83 | $24.49 | +0.27% |
| Week 4 | $19.13 | $21.85 | $24.95 | +0.36% |
| Week 5 | $18.85 | $21.87 | $25.37 | +0.45% |
| Week 6 | $18.60 | $21.89 | $25.75 | +0.54% |
| Week 7 | $18.38 | $21.91 | $26.11 | +0.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Doximity, Inc. operates a digital platform for medical professionals in the United States. The Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems.
The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool.
The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Doximity, Inc. trades at $21.59 per share and has a market capitalization of $3.95B, with a rank of 1566. The current price and market position place it among mid-sized healthcare technology stocks.
The 2026–2050 forecast shows a long-run upward trajectory, with the 2026 average price listed as $21.59 and a multi-year path to higher values, including an average of $36.52 by 2030 and $136.00 by 2050, yielding substantial cumulative upside on the forecasted path. The volatility profile indicates higher risk with annualized volatility around 50%.
A major floor 17.3% below — a decisive break under it would weaken the trend.
The nearest floor, 8.8% below — buyers have tended to step in here.
The nearest ceiling, 5.0% above — a clean break opens room to run.
A major ceiling 23.9% above — clearing it would confirm fresh momentum.
Key DOCS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DOCS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $22.21 | Sell | $21.91 | Sell |
| MA 10 | $21.67 | Buy | $21.68 | Buy |
| MA 20 | $21.03 | Buy | $21.38 | Buy |
| MA 50 | $21.66 | Buy | $21.97 | Sell |
| MA 100 | $22.94 | Sell | $25.53 | Sell |
| MA 200 | $37.32 | Sell | $33.29 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 53.10 | Neutral |
| Stoch RSI (14) | 54.94 | Neutral |
| CCI (20) | 67.62 | Neutral |
| Williams %R (14) | -36.21 | Info |
| MACD (12,26,9) | 0.20 | Buy |
| ROC (12) | 6.30 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 63.79 | Neutral |
| TRIX (15) | 0.02 | Buy |
| Awesome (5,34) | 1.35 | Buy |
| Ultimate (7,14,28) | 60.36 | Neutral |
| Momentum (10) | 1.92 | Buy |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 22.16 | Sell |
| ADX (14) | 12.47 | Neutral |
| ATR (14) | 0.51 | Info |
The near-term technical picture is neutral. The RSI(14) is 50, indicating balanced momentum, and the 50-day simple moving average is $21.90 while the 200-day simple moving average sits at $38.84. Support is reported at $19.26 and resistance at $22.55, framing a near-term range that aligns with a 30-day window of $18.20 to $25.61.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $18.01 | $21.77 | $27.87 | 0% | Neutral | |
| $21.69 | $27.05 | $35.57 | +24% | Bullish | |
| $23.28 | $29.77 | $40.51 | +37% | Bullish | |
| $26.16 | $34.16 | $47.77 | +57% | Bullish | |
| $27.78 | $36.96 | $52.86 | +70% | Bullish | |
| $26.53 | $35.90 | $52.38 | +65% | Bullish | |
| $28.46 | $39.11 | $58.08 | +80% | Bullish | |
| $31.02 | $43.26 | $65.30 | +99% | Bullish | |
| $35.93 | $50.81 | $77.84 | +133% | Bullish | |
| $40.37 | $57.85 | $89.87 | +166% | Bullish | |
| $50.62 | $77.02 | $126.81 | +254% | Bullish | |
| $81.54 | $137.43 | $246.35 | +531% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $18.01 | $21.77 | $25.40 | +0.00% |
| August 2026 | $18.14 | $21.37 | $25.81 | -1.85% |
| September 2026 | $18.58 | $22.02 | $26.87 | +3.07% |
| October 2026 | $18.46 | $22.01 | $27.08 | -0.09% |
| November 2026 | $18.16 | $21.75 | $26.96 | -1.17% |
| December 2026 | $18.57 | $22.33 | $27.87 | +2.70% |
Click any year to see its month-by-month DOCS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, DOCS could reach as high as $27.87, with a base case around $21.77 and support toward $18.01 — roughly 0% from $21.77. Price action looks broadly range-bound.
Expect DOCS to range from $21.69 to $35.57 through 2027. The $27.05 average target implies a +24% move from current prices. That is up +24% on the projected 2026 average. Buyers look set to stay in control over this stretch.
The DOCS price prediction for 2028 points to an average of $29.77 (low $23.28, high $40.51) — a potential gain of +37% on today's $21.77. Momentum favours further upside here.
In 2029, DOCS is projected to trade between $26.16 and $47.77, averaging $34.16 — a potential gain of +57% from today's $21.77. That is up +15% on the projected 2028 average. Buyers look set to stay in control over this stretch.
Doximity, Inc.'s 2030 outlook centres on $36.96, within a $27.78 to $52.86 range. That is up +8% on the projected 2029 average. That marks a +70% change versus current levels. Momentum favours further upside here.
By 2031, DOCS could reach as high as $52.38, with a base case around $35.90 and support toward $26.53 — roughly +65% from $21.77. Buyers look set to stay in control over this stretch.
Expect DOCS to range from $28.46 to $58.08 through 2032. The $39.11 average target implies a +80% move from current prices. That is up +9% on the projected 2031 average. Momentum favours further upside here.
The DOCS price prediction for 2033 points to an average of $43.26 (low $31.02, high $65.30) — a potential gain of +99% on today's $21.77. Buyers look set to stay in control over this stretch.
In 2034, DOCS is projected to trade between $35.93 and $77.84, averaging $50.81 — a potential gain of +133% from today's $21.77. That is up +17% on the projected 2033 average. Momentum favours further upside here.
Doximity, Inc.'s 2035 outlook centres on $57.85, within a $40.37 to $89.87 range. That is up +14% on the projected 2034 average. That marks a +166% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, DOCS could reach as high as $126.81, with a base case around $77.02 and support toward $50.62 — roughly +254% from $21.77. Momentum favours further upside here.
Expect DOCS to range from $81.54 to $246.35 through 2050. The $137.43 average target implies a +531% move from current prices. That is up +78% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in DOCS today (≈ 45.934773 DOCS) could be worth
$6,312.96
+$5,312.96 (+531%) by 2050 · US Dollar
Based on the average projected DOCS price of $137.43 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DOCSwould be worth at today's price.
$1,000 invested in DOCS on Jul 10, 2025 (≈ 16.644474 DOCS) would be worth
$362.35
-$637.65 (-63.8%) today · 0.36× · US Dollar
Based on a DOCS entry price of $60.08 vs. today's $21.77.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $21.86 | $995.88 | -0.4% |
| 1 month ago | $20.24 | $1,075.59 | +7.6% |
| 3 months ago | $21.05 | $1,034.2 | +3.4% |
| 6 months ago | $43.86 | $496.35 | -50.4% |
| 1 year ago | $60.08 | $362.35 | -63.8% |
| All time (5.0y) ago | $50.24 | $433.32 | -56.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DOCS forecast.
Our base-case forecast reaches $44.00 around 2034.
Implied market cap at $44.00: $5.81B
Multiyear forecasts show a bullish trajectory with rising averages and expanding upside. In 2026, the average price is $21.59 with a 0% ROI and neutral sentiment. Through 2030 the average climbs to $36.52 with a 69.2% ROI, followed by year-by-year gains (2031 $35.28, 2032 $38.89, 2033 $42.73, 2034 $50.32, 2035 $57.66) maintaining bullish sentiment.
By 2040 the average is $76.13 with a 252.6% ROI, and by 2050 the average reaches $136.00 with a 529.9% ROI. These figures illustrate a persistent long-term upside, albeit with uncertainty inherent in future price estimates.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $36.52, with a low of $27.30 and a high of $52.60, and a projected ROI of 69.2%.
Forecasts show a bullish path with averages rising beyond 2026, including an average of $36.52 in 2030 and $136.00 in 2050, with ROI figures reaching up to 529.9% by 2050. These are estimates and not guarantees.
Yes. The forecast includes a 2033 high of $65.03 and a 2034 high of $77.76, with the 2030 max at $52.60 and 2032 max at $58.21, indicating prices exceeding $50 in multiple years.
The current price is $21.59 and the market capitalization is $3.95B.
The 30-day range is from $18.20 to $25.61.
Doximity, Inc. Community Discussion
0Share your Doximity, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.